In chronic myelocytic leukemia (CML), changes in integrin-mediated interactions between leukemia cells and fibronectin allow the circulation of malignant cells [29]. This evidence concerns the gene FN1 and chronic myelogenous leukemia, BCR-ABL1 positive.